Quick Summary
Trulicity 0.75mg Injection
Last updated on 31 Mar 2026 | 09:30 AM (IST)
₹4829
MRP: ₹5669.06
(You Save ₹840.06)
2 PREFILLED SYRINGE(s)
Trulicity 0.75mg Injection
Salt Composition
DULAGLUTIDEMarketer
ELI LILLY AND COMPANY INDIA PVT LTD
Prepaid Only. Non-Returnable.
15% OFF
₹4829
MRP: ₹5,669.06
Inclusive of all taxes
15% Off
Salt Composition
DULAGLUTIDEMarketer
ELI LILLY AND COMPANY INDIA PVT LTD
Prepaid Only. Non-Returnable.
Dispatch: Today
Order In: 0h 0m 0s
0h 0m 0s
Order before timer ends to ensure your medicine is dispatched at...
Substitutes
Aplevant 0.75mg Injection
LUPIN LTD
₹ 2693.00/injection
12% costlier
Introduction
Trulicity 0.75 mg Pre-Filled Pen is an antidiabetic Trulicity injection used to help adults manage blood sugar levels in type 2 diabetes. It contains Dulaglutide, a medicine that belongs to the class of GLP-1 receptor agonists (glucagon-like peptide-1). Trulicity for type 2 diabetes works by helping your body release more insulin when blood sugar is high, reducing sugar production in the liver, slowing digestion, and decreasing appetite.
This once-weekly Trulicity diabetes treatment can be used alone or with other diabetes medicines such as metformin, especially when diet and exercise alone are not sufficient to keep blood glucose in control. Patients who start this medication often ask about Trulicity dosage 0.75 mg and How to inject Trulicity 0.75 mg, as proper technique and timing ensure best results. Always follow your doctor’s Trulicity 0.75 mg dosage instructions for diabetes, which include using the prefilled pen exactly as directed.
One of the added advantages of this therapy is its impact on weight management — many users notice a mild weight loss or stabilization over time, which helps improve metabolic health. However, it’s important to be aware of potential Trulicity 0.75 mg side effects and warnings, such as nausea, upset stomach, or mild injection site reactions, which usually reduce as the body adjusts.
For patients who need financial support, the Trulicity 0.75 mg patient assistance program can help make treatment more accessible. Those seeking to purchase it often look for Trulicity 0.75 mg price details online and compare options to ensure authenticity and affordability. Understanding your medicine, its purpose, and correct usage forms a key part of managing type 2 diabetes effectively and safely.
Uses
Management of type 2 diabetes mellitus in adults
Helps improve blood sugar control
May aid in weight management
How Trulicity 0.75mg Injection Works
Trulicity mimics the action of a natural hormone called GLP-1. It:
-
Stimulates insulin release after meals
-
Reduces the amount of sugar produced by your liver
-
Slows down food movement through your stomach (gastric emptying)
-
Helps reduce appetite
Together, these effects help lower blood sugar levels and contribute to better diabetes management.
Interaction of Trulicity 0.75mg Injection with other drugs
Inform your doctor about:
-
All prescription and OTC medications
-
Supplements or herbal products
Possible interactions:
-
Medicines like Disopyramide, Beclometasone, or Betamethasone may interfere with blood sugar control.
-
Some steroids and chemotherapy drugs may reduce the effectiveness of Trulicity or increase blood sugar.
Storage conditions
Store in a refrigerator (2°C to 8°C).
Do not freeze.
If needed, it can be kept at room temperature (below 30°C) for up to 14 days.
Keep away from heat, light, children, and pets.
Do not use if the solution appears cloudy, discoloured, or has particles.
How to Use Trulicity 0.75mg Injection
Trulicity is injected once a week, at any time of the day, with or without food. Try to take it on the same day each week for consistency. Your doctor or nurse will guide you on how and where to inject (thigh, abdomen, or upper arm). Do not stop or skip doses without consulting your doctor.
Safety Advice for Trulicity 0.75mg Injection
Breast Feeding
Women should consult a doctor while breastfeeding while taking the Trulicity 0.75mg Injection.
Alcohol
It is generally advisable to avoid consuming alcohol while taking Trulicity 0.75mg Injection. Alcohol can impair the body's immune system, making it less effective in fighting infections.
Liver
If you have a liver condition or are concerned about the safety of Trulicity 0.75mg Injection, it is recommended to consult your healthcare provider for personalized advice.
Lungs
Suppose you have a pre-existing lung condition or are concerned about the safety of the Trulicity 0.75mg Injection in your lungs. In that case, consulting with your healthcare provider for personalized advice is recommended.
Driving
People may experience side effects, including dizziness, drowsiness, or fatigue, after using Trulicity 0.75mg Injection. In that case, avoid driving or operating heavy machinery.
Pregnancy
The safety of Trulicity 0.75mg Injection use during pregnancy has not been established. If you are pregnant or planning to become pregnant, discussing the potential risks and benefits with your healthcare professional is essential.
Side Effects
Like all medicines, Trulicity may cause some side effects, though not everyone experiences them.
Common side effects:
Nausea
Vomiting
Diarrhea
Abdominal pain
Loss of appetite
Serious but rare side effects:
Pancreatitis (severe stomach pain)
Thyroid tumors (rare)
Allergic reactions (rash, itching, swelling)
Contact your doctor immediately if you notice severe abdominal pain, difficulty breathing, or swelling of your face or throat.
Expert Tips
-
Inject Trulicity in the same body area each week, but rotate the injection site to avoid irritation.
-
Eat smaller meals and avoid fatty foods if you experience nausea.
-
Keep a record of your blood sugar levels and monitor for signs of hypoglycemia, especially if you take it with insulin or sulfonylureas.
-
Never share your injection pen with anyone else, even if the needle is changed.
FAQs about Trulicity 0.75mg Injection
Q1.
Can Trulicity 0.75mg Injection be used in people with type 1 diabetes?
No, Trulicity 0.75mg Injection is specifically approved for treating type 2 diabetes and should not be used in people with type 1 diabetes. It works by stimulating the release of insulin from the pancreas in response to high blood sugar levels, which is not applicable in type 1 diabetes, where there is a lack of insulin production.
Q2.
Can Trulicity 0.75mg Injection be used in elderly patients?
Trulicity 0.75mg Injection can be used in elderly patients with type 2 diabetes. However, caution should be exercised due to the potential increased risk of renal impairment or other age-related conditions. Close monitoring of renal function and overall health is advised, and individualized treatment decisions should be made in collaboration with the healthcare professional.
Q3.
Can Trulicity 0.75mg Injection be used in people with kidney disease?
Trulicity 0.75mg Injection should be used cautiously in individuals with moderate to severe kidney impairment. Close monitoring of renal function is necessary, and the dosage may need to be adjusted based on kidney function. Discussing your kidney health with your healthcare professional before initiating it.
Q4.
Can Trulicity 0.75mg Injection be used in people with a history of cardiovascular disease?
Individuals with a history of cardiovascular disease can generally use Trulicity 0.75mg Injection, but close monitoring may be required due to potential cardiovascular effects. Discussing your history of heart-related conditions with your healthcare professional to determine the most appropriate treatment approach is important.
Q5.
What are the side effects of Trulicity 0.75mg Injection?
Common side effects of Trulicity 0.75mg Injection include gastrointestinal disturbances such as nausea, vomiting, diarrhea, and abdominal pain. Less common but more serious side effects can include pancreatitis, characterized by severe abdominal pain, and allergic reactions such as anaphylaxis. Other potential side effects include thyroid C-cell tumors, injection site reactions, and an increased heart rate.
Fact Box
Molecule name | Dulaglutide |
Therapeutic class | Antidiabetic |
Pharmacological class | Glucagon-like peptide-1 receptor agonists |
Indications | Type 2 Diabetes |
References
Eli Lilly and Company Limited, Electronic medicines compendium (EMC), [Revised on 25th May 2023], [Accessed on 31st May 2023], https://www.medicines.org.uk/emc/files/pil.3634.pdf
Eli Lilly and Company, US Food and Drug Administration, [Revised on January 2017] [Accessed on 1st June 2023], https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/125469s007s008lbl.pdf
KD Tripathi, Essentials of Medical Pharmacology, 2018, 8th Edition, 1002.
Disclaimer
MrMed’s primary intention is to ensure that its consumers get information that experts, accurate and trustworthy, review. The information and contents of this website are for informational purposes only. They are not intended to substitute for professional medical advice, diagnosis, or treatment. Please seek your doctor's advice and discuss all your queries related to any disease or medicine. Do not disregard professional medical advice or delay seeking it because of something you have read on MrMed. Our mission is to support, not replace, the doctor-patient relationship.
Did you find this information helpful?
Author Details
Written By
Sakshi Anil More
B. Pharm
Reviewed By
Dr. Tejashwin Adiga
MBBS
Last updated : 31 Mar 2026 | 09:30 AM (IST)
Want to know more?
Read Our Editorial Policy
